Inactive Instrument

Cornerstone Therapeutics, Inc. Share Price

Stocks

End-of-day quote Nasdaq
- ^USD	-

28/14/28	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
04/14/04	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
01/14/01	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
20/13/20	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
01/13/01	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

16/13/16	USA-Les valeurs à suivre à Wall Street (actualisé)
16/13/16	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	01/01/2021
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.10%	-0.77%	+17.58%	+68.76%	4.84TCr
OTSUKA HOLDINGS CO., LTD.	+0.17%	-4.06%	+52.07%	+119.41%	3.97TCr
CIPLA LIMITED	-0.60%	-0.94%	-7.29%	+16.60%	1.23TCr
ZYDUS LIFESCIENCES LIMITED	-2.75%	+1.88%	+14.81%	+72.68%	1.18TCr
KRKA, D. D.	-0.58%	-0.77%	+29.90%	+141.59%	906.17Cr
GEDEON RICHTER	+1.56%	+5.52%	+23.69%	+41.92%	756.57Cr
ONO PHARMACEUTICAL CO., LTD.	-0.25%	+0.21%	+43.60%	-13.09%	717.59Cr
GLENMARK PHARMACEUTICALS LIMITED	-0.07%	+1.72%	+13.39%	+190.73%	684.21Cr
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-2.51%	-3.14%	-30.53%	+23.06%	576.86Cr
Average	-0.57%	+1.46%	+17.47%	+73.52%	1.65TCr
Weighted average by Cap.	-0.32%	+1.00%	+24.78%	+81.27%

Employees

Sector